Corifollitropin alfa

Therapeutic indications

Corifollitropin alfa is indicated for:

Controlled Ovarian Stimulation (COS)

Population group: women, only adults (18 - 65 years old)

Corifollitropin alfa is indicated for Controlled Ovarian Stimulation (COS) in combination with a Gonadotropin Releasing Hormone (GnRH) antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypogonadotropic hypogonadism

Population group: men, only adolescents (12 years - 18 years old)

Corifollitropin alfa is indicated for the treatment of adolescent males (14 years and older) with hypogonadotropic hypogonadism, in combination with human Chorionic Gonadotropin (hCG).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Corifollitropin alfa is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Polycystic ovarian syndrome (PCOS)

Polycystic ovary syndrome

Ovarian Hyperstimulation Syndrome (OHSS)

Secondary Meig's syndrome

Malformations of the reproductive organs

Congenital anomaly of female genital system

Fibroid tumours of the uterus

Uterine leiomyoma

Ovarian cysts, enlarged ovaries

at least one of
Ovarian cyst
Ovarian enlargement

Primary ovarian failure

Primary ovarian failure

Abnormal vaginal bleeding

Abnormal vaginal bleeding

Tumours of the ovary, breast, uterus, pituitary or hypothalamus

at least one of
Neoplasm of ovary
Neoplasm of breast
Neoplasm of uterus
Neoplasm of pituitary gland
Tumor of hypothalamus

Renal impairment

Renal failure

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: ELONVA Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈